FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.
Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives.
Foundation Gives Duke $2M For Brain Tumor Research.
Democrats Say Bush Budget Neglects NSF And NASA.
Seattle Times, The Hutch Duel Over Five-Part Series.
NCI Offers Bibliography On Risk Communication.
SEER Program Expansion Through Cost-Sharing.
Toxicology Program Seeks Comment On Substances.
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
